JAZZ vs MAC · P/E 1988, rev $4.07B vs rev $918.2M
Jazz Pharmaceuticals PLC (JAZZ) versus Macerich Company (MAC) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Macerich Company (MAC) is a reit - retail company listed on US.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported MAC revenue for 2024-12-31 was $918.2M. Net income was -$197.7M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. MAC currently screens at market cap $4.41B.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. MAC currently screens at market cap $4.41B.
Not investment advice. Open the JAZZ and MAC stock pages for the full models.
Not investment advice.